H E Gabbert Selected Research

H E Gabbert Research Topics

Disease

17	Neoplasms (Cancer) 05/2015 - 04/2000
12	Renal Cell Carcinoma (Grawitz Tumor) 10/2007 - 01/2000
9	Carcinoma (Carcinomatosis) 06/2007 - 05/2000
4	Neoplasm Metastasis (Metastasis) 05/2014 - 01/2006
3	Esophageal Squamous Cell Carcinoma 01/2003 - 01/2000
3	Sarcoma (Soft Tissue Sarcoma) 10/2001 - 04/2000
2	Breast Neoplasms (Breast Cancer) 01/2007 - 01/2006
2	Necrosis 04/2006 - 03/2003
2	Inflammation (Inflammations) 04/2006 - 04/2004
2	Stomach Neoplasms (Stomach Cancer) 06/2001 - 05/2000
2	Adenocarcinoma 06/2001 - 12/2000
2	Metaplasia 01/2001 - 12/2000
1	Colorectal Neoplasms (Colorectal Cancer) 10/2007
1	Carcinogenesis 10/2007
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2007
1	Microsatellite Instability 10/2007
1	Prostatic Neoplasms (Prostate Cancer) 06/2007
1	Sarcoidosis (Schaumann Disease) 04/2006
1	Left Ventricular Dysfunction 04/2004
1	Myocarditis (Carditis) 04/2004
1	Malignant Fibrous Histiocytoma 03/2004
1	Hypertrophy 12/2002
1	Fabry Disease (Fabry's Disease) 12/2002
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2001
1	Barrett Esophagus (Barrett's Esophagus) 12/2000
1	Hepatitis 11/2000
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2000

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 10/2007 - 12/2000
3	DNA (Deoxyribonucleic Acid)IBA 10/2007 - 06/2001
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2007 - 05/2000
2	RNA (Ribonucleic Acid)IBA 06/2007 - 03/2002
2	Messenger RNA (mRNA)IBA 10/2004 - 10/2001
2	TNF-Related Apoptosis-Inducing LigandIBA 06/2003 - 03/2003
2	EnzymesIBA 01/2003 - 09/2001
2	SurvivinIBA 12/2002 - 03/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2001 - 06/2000
2	Topotecan (Hycamtin)FDA LinkGeneric 09/2001 - 11/2000
2	Retinoblastoma ProteinIBA 02/2001 - 01/2001
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2000 - 04/2000
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2000 - 01/2000
1	SynaptophysinIBA 05/2015
1	Chromogranin AIBA 05/2015
1	Serotonin (5 Hydroxytryptamine)IBA 05/2014
1	Formaldehyde (Formol)FDA Link 10/2007
1	Transforming Growth Factor-beta Type II ReceptorIBA 10/2007
1	NucleotidesIBA 10/2007
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2007
1	GTP Phosphohydrolases (GTPases)IBA 06/2007
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2007
1	Protein Isoforms (Isoforms)IBA 06/2007
1	rac GTP-Binding ProteinsIBA 06/2007
1	Phenobarbital (Luminal)FDA Link 01/2007
1	T-Lymphoma Invasion and Metastasis-inducing Protein 1IBA 10/2006
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 10/2006
1	SteroidsIBA 04/2006
1	AcidsIBA 04/2006
1	CK 17IBA 01/2006
1	Estrogens (Estrogen)FDA Link 01/2006
1	Progesterone FDA LinkGeneric 01/2006
1	AlkaloidsIBA 03/2004
1	Caspase 9IBA 06/2003
1	Pyrimidine PhosphorylasesIBA 01/2003
1	ImmunosorbentsIBA 01/2003
1	doxifluridineIBA 01/2003
1	GlycosphingolipidsIBA 12/2002
1	alpha-Galactosidase (Beano)IBA 12/2002
1	Inhibitor of Apoptosis ProteinsIBA 12/2002
1	Histidine (L-Histidine)FDA Link 04/2002
1	AntibodiesIBA 03/2002
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2002
1	Tissue Inhibitor of Metalloproteinase-2IBA 11/2001
1	Cadherins (E-Cadherin)IBA 11/2001
1	Tissue Inhibitor of MetalloproteinasesIBA 11/2001
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2001
1	Interleukin-3 (Interleukin 3)IBA 11/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2001
1	Macrophage Colony-Stimulating FactorIBA 11/2001
1	Topoisomerase I InhibitorsIBA 09/2001
1	trioctyl phosphine oxide (TOPO)IBA 09/2001
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 09/2001
1	beta CateninIBA 08/2001
1	Transaminases (Aminotransferases)IBA 11/2000
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2000
1	Cell Cycle ProteinsIBA 05/2000
1	Transforming Growth Factor alpha (TGF-alpha)IBA 05/2000
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 05/2000
1	Protein Kinase CIBA 03/2000
1	IsoenzymesIBA 03/2000

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 10/2007 - 01/2000
2	Therapeutics 05/2014 - 01/2000
2	Prostatectomy (Retropubic Prostatectomy) 06/2007 - 10/2006
2	Radiotherapy 03/2004 - 04/2000
2	Esophagectomy 06/2001 - 12/2000
1	Injections 04/2006
1	Enzyme Replacement Therapy 12/2002
1	Catheters 12/2002
1	Combined Modality Therapy 09/2001
1	Chemoradiotherapy 09/2001